Managed Healthcare Executive December 17, 2024
Denise Myshko

A new bill in Congress would require pass-through prices in both Medicare, and Medicaid and require transparency of PBM practices in the commercial space.

Congress is working on an end-of-year package for funding the government through March 2025 that includes some changes for pharmacy benefit managers (PBMs) and group purchasing organizations. The proposed bill as currently written includes changes to Medicare and Medicare and includes some measures around transparency of PBM practices in the commercial space.

Patrick Cooney, president of the lobby group The Federal Group, said the big surprise is the changes that will impact the commercials plans.

“We’ve expected changes, but the new element is PBM reform,” he said in an interview. “Congress is also going to institute...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Closing the women’s health gap: Biopharma’s untapped opportunity
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
DOJ Accuses Walgreens of Filling Millions of Illegitimate Prescriptions

Share This Article